The board of directors of Shanghai Haohai Biological Technology Co., Ltd. announced that Mr. Ling Xihua, an executive director, the chief financial officer and a member of the remuneration committee of the company, passed away on 12 January 2016. To ensure a seamless transition, Mr. Ling's responsibilities will be temporarily taken up by Mr. Huang Ping, an executive director, the Board secretary and the joint company secretary of the company who has been working closely with Mr. Ling during his tenure on the company's business and financial management matters with effect from 12 January 2016.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.55 HKD | +2.28% | +1.31% | +5.58% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.58% | 1.89B | |
-7.16% | 177B | |
-4.86% | 65.54B | |
-4.28% | 47.09B | |
+10.32% | 43.43B | |
+8.14% | 41.77B | |
+15.76% | 29.55B | |
+15.53% | 24.83B | |
-5.88% | 23.97B | |
-5.38% | 23.54B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Shanghai Haohai Biological Technology Co., Ltd. Announces Executive Changes